 Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26
Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores
NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores
IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores 
              Tejnaksh Healthcare Ltd's Promoter & Director, Ashish Rawandale has purchased 9411 equity shares of the company through Market Purchase in BSE. The shares were bought for a total amount of Rs. 557246.
With this acquisition, the shareholding of Ashish Rawandale has increased from 3778100 (37.2%) to 3787511 (37.29%). The shares were acquired during the period 4/1/2019 to 4/1/2019.
| Promoter Entity | Shares Acquired / Sold | Date / Period | Holding - Pre Transaction | Holding - Post Transaction | 
| Ashish Rawandale | 9411 | 4/1/2019 to 4/1/2019 | 3778100 (37.2%) | 3787511 (37.29%) |